Published in
Springer, Breast Cancer Research and Treatment, 2(163), p. 295-302, 2017
DOI: 10.1007/s10549-017-4191-y
Links
Tools
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
Journal article published in 2017 by
M. V. Dieci,
A. Frassoldati,
D. Generali,
G. Bisagni,
F. Piacentini 
,
L. Cavanna,
K. Cagossi,
F. Puglisi,
A. Michelotti,
R. Berardi,
G. Banna,
A. Goubar,
G. Ficarra,
G. Griguolo,
Pierfranco Conte
and other authors.
,
L. Cavanna,
K. Cagossi,
F. Puglisi,
A. Michelotti,
R. Berardi,
G. Banna,
A. Goubar,
G. Ficarra,
G. Griguolo,
Pierfranco Conte
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 